Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Go back to Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
(NASDAQ: ANIX) Delayed: 2.77 --0 (-0%)
Previous Close $2.77    52 Week High
Open $2.77    52 Week Low
Day High $2.77    P/E N/A 
Day Low $2.77    EPS
Volume 20